Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
2.
Naunyn Schmiedebergs Arch Pharmacol ; 395(12): 1509-1523, 2022 12.
Article in English | MEDLINE | ID: mdl-36125533

ABSTRACT

The 4,4'-diaminodiphenyl sulfone (DDS), also known as dapsone, is traditionally used as a potent anti-bacterial agent in clinical management of leprosy. For decades, dapsone has been among the first-line medications used in multidrug treatment of leprosy recommended by the World Health Organization (WHO). Shortly after dapsone's discovery as an antibiotic in 1937, the dual function of dapsone (anti-microbial and anti-inflammatory) was elucidated. Dapsone exerts its anti-bacterial effects by inhibiting dihydrofolic acid synthesis, leading to inhibition of bacterial growth, while its anti-inflammatory properties are triggered by inhibiting reactive oxygen species (ROS) production, reducing the effect of eosinophil peroxidase on mast cells and downregulating neutrophil-mediated inflammatory responses. Among the leading mechanisms associated with its anti-microbial/anti-protozoal effects, dapsone clearly has multiple antioxidant, anti-inflammatory, and anti-apoptotic functions. In this regard, it has been described in treating a wide variety of inflammatory and infectious skin conditions. Previous reports have explored different molecular targets for dapsone and provided insight into the anti-inflammatory mechanism of dapsone. This article reviews several basic, experimental, and clinical approaches on anti-inflammatory effect of dapsone.


Subject(s)
Dapsone , Leprosy , Humans , Dapsone/pharmacology , Dapsone/therapeutic use , Leprosy/drug therapy , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Antioxidants/therapeutic use , Reactive Oxygen Species
3.
Oxid Med Cell Longev ; 2019: 2082561, 2019.
Article in English | MEDLINE | ID: mdl-31354902

ABSTRACT

Multiple sclerosis (MS) is a heterogeneous autoimmune disease of unknown etiology characterized by inflammation, demyelination, and axonal degeneration that affects both the white and gray matter of CNS. Recent large-scale epidemiological and genomic studies identified several genetic and environmental risk factors for the disease. Among them are environmental factors of infectious origin, possibly causing MS, which include Epstein-Barr virus infection, reactivation of some endogenous retrovirus groups, and infection by pathogenic bacteria (mycobacteria, Chlamydia pneumoniae, and Helicobacter pylori). However, the nature of the events leading to the activation of immune cells in MS is mostly unknown and there is no effective therapy against the disease. Amazingly, whatever the cause of the disease, signs of damage to the nerve tissue with MS lesions were the same as with infectious leprosy, while in the latter case nitrozooxidative stress was suggested as the main cause of the nerve damage. With this in mind and following the hypothesis that excessive production of mitochondrial reactive oxygen species critically contributes to MS pathogenesis, we studied the effect of mitochondria-targeted antioxidant SkQ1 in an in vitro MS model of the primary oligodendrocyte culture of the cerebellum, challenged with lipopolysaccharide (LPS). SkQ1 was found to accumulate in the mitochondria of oligodendrocytes and microglial cells, and it was also found to prevent LPS-induced inhibition of myelin production in oligodendrocytes. The results implicate that mitochondria-targeted antioxidants could be promising candidates as components of a combined therapy for MS and related neurological disorders.


Subject(s)
Antioxidants/therapeutic use , Mitochondria/drug effects , Multiple Sclerosis/drug therapy , Plastoquinone/analogs & derivatives , Antioxidants/pharmacology , Humans , Multiple Sclerosis/pathology , Plastoquinone/pharmacology , Plastoquinone/therapeutic use
4.
Indian J Dermatol Venereol Leprol ; 84(3): 269-274, 2018.
Article in English | MEDLINE | ID: mdl-29491190

ABSTRACT

BACKGROUND: Vitiligo is a disorder caused by the loss of the melanocyte activity on melanin pigment generation. Studies show that oxidative-stress induced apoptosis in melanocytes is closely related to the pathogenesis of vitiligo. Glutamine is a well known antioxidant with anti-apoptotic effects, and is used in a variety of diseases. However, it is unclear whether glutamine has an antioxidant or anti-apoptotic effect on melanocytes. AIMS: The aim of this study was to investigate the protective effects of glutamine on a human melanocyte oxidative stress model. METHODS: The oxidative stress model was established on human melanocytes using hydrogen peroxide. The morphology and viability of melanocytes, levels of oxidants [reactive oxygen species and malondialdehyde], levels of antioxidants [superoxide dismutase and glutathione-S-transferase], and apoptosis-related indicators (caspase-3, bax and bcl-2) were examined after glutamine exposure at various concentrations. Expressions of nuclear factor-E2-related factor 2, heme oxygenase-1, and heat shock protein 70 were detected using western blot technique after glutamine exposure at various concentrations. RESULTS: Our results demonstrate that pre-treatment and post-treatment with glutamine promoted melanocyte viability, increased levels of superoxide dismutase, glutathione-S-transferase and bcl-2, decreased levels of reactive oxygen species, malondialdehyde, bax and caspase-3, and enhanced nuclear factor-E2-related factor 2, heme oxygenase-1, and heat shock protein 70 expression in a dose dependent manner. The effect of pre-treatment was more significant than post-treatment, at the same concentration. LIMITATIONS: The mechanisms of glutamine activated nuclear factor-E2-related factor 2 antioxidant responsive element signaling pathway need further investigation. CONCLUSIONS: Glutamine enhances the antioxidant and anti-apoptotic capabilities of melanocytes and protects them against oxidative stress.


Subject(s)
Antioxidants/pharmacology , Glutamine/pharmacology , Melanocytes/drug effects , Oxidative Stress/drug effects , Adolescent , Adult , Antioxidants/therapeutic use , Apoptosis/drug effects , Apoptosis/physiology , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , Dose-Response Relationship, Drug , Glutamine/therapeutic use , Humans , Hydrogen Peroxide/toxicity , Male , Melanocytes/metabolism , Oxidative Stress/physiology , Vitiligo/drug therapy , Vitiligo/metabolism , Young Adult
5.
Article in English | MEDLINE | ID: mdl-29243674

ABSTRACT

Turmeric (Curcuma longa L.) is an integral part of Asian culture and cuisine. It has been used in traditional medicine since centuries. A myriad of health benefits have been attributed to it. Curcumin, the most biologically active curcuminoid in turmeric, is being investigated in pre-clinical and clinical trials for its role in disease prevention and cure. It has antioxidant, anti-inflammatory, antineoplastic, anti-proliferative and antimicrobial effects. We review the chemistry of this plant, its cultural relevance in Indian skin care, and its uses in dermatology.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Condiments , Cosmetics/administration & dosage , Curcumin/therapeutic use , Plants, Medicinal , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/isolation & purification , Antineoplastic Agents/isolation & purification , Antineoplastic Agents/therapeutic use , Antioxidants/isolation & purification , Antioxidants/therapeutic use , Cosmetics/isolation & purification , Curcumin/administration & dosage , Curcumin/isolation & purification , Humans , Plants, Medicinal/chemistry
6.
J Pharm Pharmacol ; 66(10): 1351-68, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24780055

ABSTRACT

OBJECTIVES: Caralluma is a xerophytic genus used as traditional medicine for the treatment of diabetes, inflammation, leprosy, obesity and rheumatism. Objectives of this review are to establish a relationship between traditional uses and scientific studies by critically evaluating the available fragmented literature on ethnobotany, pharmacology, phytochemistry and toxicology of genus Caralluma. KEY FINDINGS: Ethnomedical uses of Caralluma have been recorded from various countries such as China, India, Iran and Pakistan for six major classes of diseases including diabetes and gastrointestinal disorders. This review indicated the efficacy of genus Caralluma in several in vitro and in vivo pharmacological properties such as antimicrobial, antioxidant and anticancer activity. These bioactivity might be due to the presence of certain classes of compounds in genus Caralluma including pregnane glycosides, flavonoid glycosides and flavones. SUMMARY: Traditional uses and scientific evaluation of Caralluma indicates that it is one of the most widely used genus in some parts of the world. Further studies on the structural activity relationship of some of the isolated compound may improve their biological potency as well as scientific exploitation of traditional uses of the genus.


Subject(s)
Apocynaceae/chemistry , Phytotherapy , Plant Extracts/therapeutic use , Anti-Infective Agents/pharmacology , Anti-Infective Agents/therapeutic use , Antineoplastic Agents, Phytogenic/pharmacology , Antineoplastic Agents, Phytogenic/therapeutic use , Antioxidants/pharmacology , Antioxidants/therapeutic use , Ethnobotany , Humans , Plant Extracts/pharmacology
7.
Nutr Hosp ; 29(1): 26-36, 2014 Jan 01.
Article in English | MEDLINE | ID: mdl-24483959

ABSTRACT

Leprosy is a chronic infectious disease caused by Mycobacterium leprae, an intracellular bacillus of airborne transmission. The disease affects the skin and peripheral nerves and can cause neurological sequelae. The bacillus multiplies slowly in the host and the disease probably occurs due to malfunctioning in host immune response. This review addresses the role of some specific micronutrients in the immune response, such as Vitamins A, D, E, C, Zinc and Selenium, detailing their mechanisms of actions in infectious diseases, and in leprosy. The immune response to pathogens releases harmful substances, which lead to tissue damage. This review discusses how a decreased level of antioxidants may contribute to an increased oxidative stress and complications of infectious diseases and leprosy. As the nutrients have a regulatory effect in the innate and adaptative immune responses, a perfect balance in their concentrations is important to improve the immune response against the pathogens.


Subject(s)
Leprosy/immunology , Micronutrients , Antioxidants/therapeutic use , Humans , Mycobacterium leprae/immunology , Vitamins/therapeutic use
8.
Article in English | MEDLINE | ID: mdl-22772611

ABSTRACT

Melasma is one of the most common and distressing pigmentary disorders presenting to dermatology clinics. The precise cause of melasma remains unknown; however, there are many possible contributing factors. It is notably difficult to treat and has a tendency to relapse. The existing and most tried topical therapy is hydroquinone and the triple combination with tretinoin and corticosteroids, which is considered the gold standard for melasma. Besides that, azelaic acid, kojic acid, arbutin, ascorbic acid, glycolic acid and salicylic peels have also been tried with limited success. However, multiple novel topical agents are being investigated for their potential as hypopigmenting agents with unique mode of action. But, further trials are required to study their efficacy and safety before they can be further recommended. The article highlights these newer formulations and also briefly mentions about the newer chemical peels and the much hyped lasers in treating this difficult and frustrating condition.


Subject(s)
Dermatologic Agents/therapeutic use , Melanosis/therapy , Antioxidants/therapeutic use , Chemexfoliation , Dermatologic Agents/administration & dosage , Drug Therapy, Combination , Humans , Lasers, Gas/therapeutic use , Lasers, Solid-State/therapeutic use
9.
Curr Opin Clin Nutr Metab Care ; 12(6): 646-52, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19710611

ABSTRACT

PURPOSE OF REVIEW: Zinc is essential for multiple cellular functions including immunity. Many investigators have used zinc supplementation in an attempt to affect the outcome of various diseases. These efforts were aimed at either supporting immunity by zinc administration or correcting the zinc dependent immune functions in zinc deficient individuals. RECENT FINDINGS: In this review, recent findings of zinc supplementation in various diseases have been presented. Beneficial therapeutic response of zinc supplementation has been observed in the diarrhea of children, chronic hepatitis C, shigellosis, leprosy, tuberculosis, pneumonia, acute lower respiratory tract infection, common cold, and leishmaniasis. Zinc supplementation was effective in decreasing incidences of infections in the elderly, in patients with sickle cell disease (SCD) and decreasing incidences of respiratory tract infections in children. Zinc supplementation has prevented blindness in 25% of the elderly individuals with dry type of AMD. Zinc supplementation was effective in decreasing oxidative stress and generation of inflammatory cytokines such as TNF-alpha and IL-1beta in elderly individuals and patients with SCD. SUMMARY: Zinc supplementation has been successfully used as a therapeutic and preventive agent for many conditions. Zinc functions as an intracellular signal molecule for immune cells.


Subject(s)
Anemia, Sickle Cell/drug therapy , Antioxidants/therapeutic use , Infections/drug therapy , Inflammation/drug therapy , Macular Degeneration/drug therapy , Oxidative Stress/drug effects , Zinc/therapeutic use , Aged , Antioxidants/pharmacology , Blindness/prevention & control , Child , Chronic Disease , Cytokines/biosynthesis , Dietary Supplements , Humans , Immune System/drug effects , Zinc/deficiency , Zinc/pharmacology
10.
Eur J Clin Nutr ; 59(10): 1121-8, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16015260

ABSTRACT

BACKGROUND: A constellation of reactive oxygen species (ROS) capable of damaging cellular constituents generated in excess during the chronic, inflammatory, neurodegenerative disease process of leprosy. The consequences of this leads to enhanced oxidative stress and lower antioxidant status. Enzymatic antioxidants provide first line defense against ROS. We have measured the levels of oxidative stress indices like lipid peroxidation (LPO), protein carbonyls together with enzymatic antioxidants in the blood samples of control and leprosy patients. Nutritional rehabilitation by way of exogenous supplementation of functionally efficient antioxidants like vitamin E reactivates the enzymatic antioxidant system and guards against the insult caused by ROS during the pathogenesis of the disease and antileprosy chemotherapy. DESIGN: Untreated leprosy patients were selected on the basis of clinical examination and skin smear. All diagnosed untreated leprosy patients received multi drug therapy (MDT) consisting of rifampicin, dapsone and clofazimine as recommended by World Health Organization. A small number of untreated cases were selected for co-supplementation of vitamin E along with MDT. Oxidative stress indices, enzymatic and nonenzymatic antioxidant status were assayed in untreated, MDT treated and those supplemented vitamin E along with MDT. STATISTICAL METHODS: We have compared the significance in the mean+/-s.d. values of the oxidative stress indices and the levels of antioxidants using one way analysis of variance (ANOVA) between control, untreated, MDT treated and those supplemented vitamin E with MDT and the results were significant at P < 0.05. Statistical analysis of the results suggests that oral administration of vitamin E lowers oxidative stress and augments antioxidant status in affected individuals. RESULTS: Enhanced oxidative stress as evidenced by increased LPO and protein carbonyl in leprosy cases lowers the antioxidant status. Treatment with MDT has a limited impact on increased oxidative stress and decreased antioxidant status. Coadministration of vitamin E along with MDT decreases oxidative stress and activate the antioxidant status. DISCUSSION: The excess production of ROS as seen in leprosy cases could lead to degeneration of tissues and derangement of internal organs. The possible reason for the decreased antioxidant status in leprosy cases may be increased production of ROS, deranged liver function, and the free radical producing ability of drugs used in MDT of leprosy. Intervention with antioxidant supplementation like vitamin E prevents oxidative stress mediated through ROS and activates the net antioxidant status during the chronic course of the disease and antileprosy chemotherapy.


Subject(s)
Antioxidants/therapeutic use , Leprosy/metabolism , Oxidative Stress/drug effects , Vitamin E/therapeutic use , Adult , Analysis of Variance , Antioxidants/physiology , Catalase/metabolism , Dietary Supplements , Female , Glutathione Peroxidase/metabolism , Glutathione Reductase/metabolism , Glutathione Transferase/metabolism , Humans , Leprostatic Agents/pharmacology , Leprosy/drug therapy , Lipid Peroxidation/drug effects , Male , Middle Aged , Oxidative Stress/physiology , Reactive Oxygen Species/metabolism , Superoxide Dismutase/metabolism , Treatment Outcome , Vitamin E/physiology
11.
s.l; Argentina. Instituto de Investigaciones Leprológicas; 1991. 222 p. tab, ilus. (66904).
Monography in Spanish | BINACIS | ID: bin-66904

ABSTRACT

Se presenta una concepción etiopatogénica y terapéutica de la Lepra, diferente de la clásica. Texto sencillo y denso, escrito por un leprólogo con "Curriculum Vitae" extenso y destacado. Interesante para quienes deseen conocer más sobre el mal de Hansen. La única objeción de peso que hemos encontrado es que no hay ningún estudio estadístico de casos y controles o ensayos clínicos experimentales (en el libro) que avale lo propuesto por el autor


Subject(s)
Humans , Leprosy/etiology , Sulfones/therapeutic use , Mycobacterium leprae/physiology , Leprosy/physiopathology , Leprosy/drug therapy , Sulfones/adverse effects , Sulfones/pharmacology , Vitamin E/therapeutic use , Thalidomide/therapeutic use , Fatty Acids, Unsaturated/adverse effects , Antioxidants/therapeutic use , Mycobacterium leprae , Mycobacterium leprae/pathogenicity
SELECTION OF CITATIONS
SEARCH DETAIL